Hansen Medical, a Mountain View developer of medical robotics for accurate positioning, manipulation and stable control of catheters, has set its proposed IPO terms.

It plans to trade on the Nasdaq under ticker symbol HNSN, and trade 6.25 million common shares priced at between $11 and $13 per share. The company has raised around $57 million in VC funding since its 2002 inception, from firms like Prospect Venture Partners, Skyline Ventures, Thomas Weisel Healthcare Partners, De Novo Ventures and Vanguard Ventures, according to PE Week.